title: Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA.
abstract: The knowledge about molecular factors driving simple ligand-DNA interactions is still limited. The aim of the present study was to investigate the electrostatic and non-electrostatic contributions to the binding free energies of anthracycline compounds with DNA. Theoretical calculations based on continuum methods (Poisson-Boltzmann and solvent accessible surface area) were performed to estimate the binding free energies of five selected anthracycline ligands (daunomycin, adriamycin, 9-deoxyadriamycin, hydroxyrubicin, and adriamycinone) to DNA. The free energy calculations also took into account the conformational change that DNA undergoes upon ligand binding. This conformational change appeared to be very important for estimating absolute free energies of binding. Our studies revealed that the absolute values of all computed contributions to the binding free energy were quite large compared to the total free energy of binding. However, the sum of these large positive and negative values produced a small negative value of the free energy around -10 kcal/mol. This value is in good agreement with experimental data. Experimental values for relative binding free energies were also reproduced for charged ligands by our calculations. Together, it was found that the driving force for ligand-DNA complex formation is the non-polar interaction between the ligand and DNA even if the ligand is positively charged.
authors.affiliation: Department of Pharmacology, University of California, San Diego, CA 92093-0365, USA.
authors.forename: M
authors.initials: M
authors.lastname: Baginski
authors.forename: F
authors.initials: F
authors.lastname: Fogolari
authors.forename: J M
authors.initials: JM
authors.lastname: Briggs
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000378:metabolism*; D004247:DNA / Q000737:chemistry / Q000378:metabolism*; D003630:Daunorubicin / Q000378:metabolism; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000378:metabolism; D015251:Epirubicin / Q000031:analogs & derivatives / Q000378:metabolism; D008024:Ligands; D008958:Models, Molecular; D008968:Molecular Conformation; D015394:Molecular Structure; D009279:Naphthacenes / Q000378:metabolism; D009690:Nucleic Acid Conformation; D012492:Salts / Q000494:pharmacology; D013816:Thermodynamics
chemical_list: D000903:Antibiotics, Antineoplastic; D008024:Ligands; D009279:Naphthacenes; D012492:Salts; C010012:adriamycin aglycone; D015251:Epirubicin; C042907:3'-deamino-3'-hydroxydoxorubicin; D004317:Doxorubicin; D004247:DNA; D003630:Daunorubicin